Drug Shortage Report for CELLCEPT
Report ID | 237837 |
Drug Identification Number | 02192748 |
Brand name | CELLCEPT |
Common or Proper name | Mycophenolate mofetil |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | MYCOPHENOLATE MOFETIL |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 10 x Blister packs of 10 |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-10-07 |
Actual start date | 2024-10-07 |
Estimated end date | 2024-11-13 |
Actual end date | 2024-11-12 |
Shortage status | Resolved |
Updated date | 2024-11-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-11-13 | French | Compare |
v8 | 2024-11-13 | English | Compare |
v7 | 2024-11-04 | French | Compare |
v6 | 2024-11-04 | English | Compare |
v5 | 2024-11-04 | French | Compare |
v4 | 2024-11-04 | English | Compare |
v3 | 2024-10-08 | English | Compare |
v2 | 2024-09-17 | French | Compare |
v1 | 2024-09-17 | English | Compare |
Showing 1 to 9 of 9